AstraZeneca PLC - Cash and Equivalents

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-and-Equivalents" stands at 8.14 Billion United States Dollars as of 09/30/2025, the highest value since 09/30/2021.

As of the end of AstraZeneca PLC's third quarter, the item "Cash and Equivalents" stands at 8.14 Billion USD. This represents an increase of 15.28 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 70.13 percent compared to the value the year prior.
The 1 year change in percent is 70.13.
The 3 year change in percent is 84.30.
The 5 year change in percent is 1.05.
The 10 year change in percent is 99.53.

The Serie's long term average value is 5.90 Billion United States Dollars. It's latest available value, on 09/30/2025, is 37.92 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2015, to it's latest available value, on 09/30/2025, is +549.02%.
The Serie's change in percent from it's maximum value, on 06/30/2021, to it's latest available value, on 09/30/2025, is -47.70%.